Aer Therapeutics
Signal active
Organization
Contact Information
Overview
Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.
About
Industries
Biotechnology, Health Care, Medical, Therapeutics
Founded
2014
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Aer Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $576.0M in funding across 16 round(s). With a team of 1-10 employees, Aer Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Aer Therapeutics, raised $36.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
3
Lead Investors
0
Total Funding Amount
$36.0M
Details
1
Aer Therapeutics has raised a total of $36.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 36.0M |
Investors
Aer Therapeutics is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Canaan Partners | - | FUNDING ROUND - Canaan Partners | 36.0M |
| Christy L. Shaffer | - | FUNDING ROUND - Christy L. Shaffer | 36.0M |
| Aer Therapeutics | - | FUNDING ROUND - Aer Therapeutics | 36.0M |
| Hatteras Venture Partners | - | FUNDING ROUND - Hatteras Venture Partners | 36.0M |
Recent Activity
There is no recent news or activity for this profile.